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Abstract Background: Over the past 21 years, we have performed more than 200
subtotal splenectomies, in which the upper splenic pole vascularized only by the
gastrosplenic pole vascularized only by the gastrosplenic vessels is preserved, to
treat different pathologic conditions. A meticulous follow-up of the postoperative
results of this procedure is of fundamental importance.
Methods: All patients undergoing subtotal splenectomy were invited to be re-
viewed. A total of 86 patients who had undergone surgery 1e20 years ago were
gathered; the surgical procedure was performed for one of the following condi-
tions: portal hypertension due to schistosomiasis (n ¼ 43), trauma (n ¼ 31), Gau-
cher’s disease (n ¼ 4), myeloid hepatosplenomegaly due to myelofibrosis (n ¼ 3),
splenomegalic retarded growth and sexual development (n ¼ 2), severe pain due
to splenic ischemia (n ¼ 2) and pancreatic cystadenoma (n ¼ 1). Patients under-
went a hematological examination, an immunological assessment, abdominal ultra-
sonography, computed tomography, scintigraphy and endoscopy.
Results: Increased white blood cell count and platelets were the only hematologi-
cal abnormalities. No immunological deficit was found. Esophageal varices were
still present in patients who underwent surgery because of portal hypertension
although without rebleeding. The ultrasound, tomography and scintigraphy exami-
nations confirmed the presence of functional splenic remnants without significant
size alteration.
Conclusions: Subtotal splenectomy seems to be a safe procedure that can be useful
in treating conditions involving the spleen. The functions of the splenic remnants
are preserved during long periods of time.
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Our studies relating to subtotal splenectomy pre-
serving the upper pole vascularized by the spleno-
gastric vessels began in 1979. After 5 years ofblished by Elsevier Ltd. All rights reserved.
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cats, dogs and pigs, we were authorized by our Insti-
tution to operate on patients with portal hyperten-
sion due to schistosomiasis and previous variceal
bleeding, and later extending to other diseases.1e9
In an attempt to preserve the splenic function,
we maintained the upper splenic pole (subtotal
splenectomy). Previously we had combined this
procedure with a splenorenal shunt.10e13 In the
presence of hepatic failure, cardiopulmonary con-
gestive dysfunction or encephalopathy, especially
in patients over 40 years of age, we combine the
subtotal splenectomy with external portal variceal
disconnection and suture gastric and esophageal
varices, through an anterior gastrotomy.14 We find
this option better than a portal systemic shunt.
Subtotal splenectomy was also performed in
patients with Gaucher’s disease in which giant
splenomegaly caused abdominal discomfort, respi-
ratory distress and walking difficulties.15,16 A total
splenectomy in this disease frequently causes liver
enlargement and bone fractures due to deposi-
tion of glucocerebroside.17e20 Lethal infection is
another complication that may follow total splenec-
tomy.20 To avoid this complication, partial splenec-
tomy, preserving the splenic pedicle, has been
proposed.17,18 However, several reports have de-
scribed splenic remnant enlargement, leading to re-
current hypersplenism.19,20 The maintenance of the
upper pole vascularized by the splenogastric vessels
potentially avoids some of those complications and
does not result in spleen enlargement.15,21,22
Myeloid hepatosplenomegaly due to myelofibro-
sis is another disease that may induce an extraordi-
nary enlargement of the spleen.23 The giant spleen
leads not only leads to the same discomfort similar
to that described in Gaucher’s disease, but also to
severe hematological complications.24e26 Even
though total splenectomy may be helpful in myeloid
hepatosplenomegaly this procedure results in great
morbidity and mortality.23,24,26e28 Postoperative
massive liver enlargement and rupture due to mye-
loid hepatomegaly, infections and bleeding are the
most frequent complications of total splenec-
tomy.24,26e30 Splenic artery ligation and partial
splenectomy with preservation of the splenic pedi-
cle are only palliative, since symptoms and splenic
enlargement usually recur.29e33 Preservation of the
uppermost part of the spleen vascularized only by
the splenogastric vessels maintains splenic function
without enlargement of the organ.21,34
In trauma, the spleen is almost always normal
and there is no reason to remove this important
organ. The multiple complications of the asplenic
condition, including severe sepsis and precocious
death, are well established in the literature.35,36 Inorder to prevent such adverse events, non-opera-
tive management and surgical procedures that pre-
serve the spleen are routinely performed at most of
advanced emergency services.37e39 Injuries to the
splenic pedicle have challenged both non-operative
management and conservative operations. In these
cases, we have successfully performed subtotal
splenectomy, preserving the upper splenic pole
supplied only by the splenogastric vessels.
Traditionally, distal pancreatectomy has in-
cluded total splenectomy.40,41 Preservation of the
spleen after ligation of its pedicle and mainte-
nance of its main branches have been proposed
in the literature.40e44 However, when it is not pos-
sible to preserve the splenic pedicle or its major
branches, the surgeon may still preserve the upper
pole supplied by the splenogastric vessels.45
According to published reports, the presence of
splenomegaly in children and teenagers leads to
retarded of growth and late sexual development,
and therefore total splenectomy is frequently
indicated.46 However, in our experience subtotal
splenectomy is sufficient to induce normal
growth.47 Patients who were operated by us using
this procedure reached normal somatic and sexual
development in less than 2 years.
Another indication for total splenectomy is
leukemia and lymphomas that are difficult to
control with chemotherapeutic drugs. Even in these
cases, subtotal splenectomy is a better option due
to the maintenance of the splenic defense capabil-
ities without the adversities of splenomegaly.48
Vascular thrombosis and splenic malformations
may provoke severe pain that does not respond to
regular analgesic drugs. In these cases, removal of
the spleen is indicated. To avoid the complications
of the asplenic condition, we have performed
laparoscopic subtotal splenectomy. This operation
preserves the upper splenic pole with its proper
vessels that prevent the effects of vascular pedicle
thrombosis.49,50
The present paper describes the late follow-up
of 86 patients that are a subpopulation of the more
than 200 patients who underwent subtotal splenec-
tomy during the past 22 years at our institution.
Methods
We assessed 86 patients who had undergone sub-
total splenectomy (Fig. 1) from 1 to 21 years previ-
ously for one of the following conditions: portal
hypertension due to schistosomiasis with previous
variceal bleedings (n ¼ 43), trauma (n ¼ 31; 24 pa-
tients with grade III severe splenic parenchyma
trauma and 7 with grade IV, splenic parenchyma
and vascular pedicle damage), Gaucher’s disease
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fibrosis (n ¼ 3), splenomegalic retarded growth and
sexual development (n ¼ 2), severe pain caused
by splenic ischemia (n ¼ 2) and cystadenoma of
the pancreatic tail (n ¼ 1). Other patients who had
undergone the procedure refused to undergo the
examinations or did not return and were excluded
from the present investigation. There were 55
men and 31 women in this study group. Their ages
at the time of this study ranged from 17 to 81
(44.4  18.8) years at the time of the present study.
In addition to answering questions related to
their disease, operation and postoperative period
the patients underwent complete physical exami-
nation. Complementary examinations included
laboratory hematological and immunological (IgM,
IgA, IgG, and active B and T lymphocytes) evalu-
ation, upper GI endoscopy, abdominal ultrasonog-
raphy, abdominal CT scan and splenic scintigraphy
with 99mTc sulfur colloid.
Results
All patients were satisfied with the results of the
operation. They had no severe complications in the
postoperative period. According to pathologic
condition, specific postoperative findings were
recorded as follows.
Portal hypertension due to schistosomiasis
Episodes of fever (higher than 37.5 C) not related
to signs of infection occurred in 26 patients, but
one patient was diagnosed with pneumonia in the
postoperative period successfully treated with anti-
biotics. At physical examination following surgery,
discrete (n ¼ 8) or moderate (n ¼ 2) ascites was
Figure 1 Surgical aspect of subtotal splenectomy per-
formed in a patient with portal hypertension. Observe
the splenogastric vessels (arrow).found in 10 patients with portal hypertension who
underwent external portal variceal disconnection.
There was no evidence of hepatic or renal distur-
bances among these patients. Six patients had
supraumbilical median incisional hernias. Postoper-
ative prothrombin times were 64% and 100% of refer-
ence values. However, in the preoperative period,
the prothrombin time in patients with portal hyper-
tensionwas41e79%of referencetimewithoutclinical
manifestations. Endoscopy revealed esophageal vari-
ces in 33 patients and gastric varices in 12 patients
who had undergone the treatment for portal hyper-
tension. These varices were of smaller size than those
found in the preoperative period. No signs suggesting
bleeding risk were found in any of these patients.
Trauma
Fever not related to signs of infection occurred in
eight patients, five with grade III severe splenic
parenchyma trauma and three with parenchyma
and vascular pedicle grade IV splenic trauma.
Gaucher’s disease
All of these patients had a palpable liver at 3e5 cm
below the rib cage.
Myeloid hepatosplenomegaly due
to myelofibrosis
One patient had pneumonia in the postoperative
period treated with antibiotics. All patients pre-
sented hepatomegaly at the level of the right rib
frame.
The hematological examination of patients in all
groups revealed a red cell count ranging from 4.0
to 5.6  106/ml. The white cell count ranged be-
tween 3400 and 47,000/ml, even without septic
manifestations. In the preoperative period, the
white cell count ranged from 1100 to 9400/ml,
with lower values in patients with portal hyperten-
sion. HowelleJolly bodies, characteristic of asple-
nia, were not found in this series.
Platelet levels ranged from 135  103 to
430  103/ml except for two patients, one with
portal hypertension (2055  106) and the other
with myeloid hepatosplenomegaly (2.142  106).
Neither patient presented signs of coagulopathy
in the postoperative period. Before the operation,
the number of platelets ranged between 18 and
191  103/ml, with no clinical abnormalities.
The immunological pattern showed normal level
of immunoglobulins in all patients. IgM ranged
between 82 and 235 mg/100 ml, IgA from 141 to
Followeup of subtotal splenectomy 175604 mg/100 ml, and IgG from 1000 to 2314 mg/
100 ml. The levels of lymphocytes were normal in
all patients. Active B lymphocyte levels ranged
from 11 to 19/mm3, and T lymphocyte levels from
23 to 52/mm3.
The ultrasound examination showed splenic rem-
nant ranging from 2.9 to 18.1 cm in 30 patients. The
portal vein revealed thrombosis of the left branch in
10 patients, with no clinical manifestations. CT
scans showed the splenic upper pole stump supplied
by the splenogastric vessels (Fig. 2). Scintigraphic
images of the splenic remnants were positive in 54
cases (Fig. 3). Twelve of the patients did not present
for the splenic scintigraphic image and 20 patients
did not receive authorization for this examination.
Discussion
All patients who underwent subtotal splenectomy
are registered in our hospital, but unfortunately
we could not contact more than 40% of them. This
difficulty is very common in Brazil because of
widespread population migration. On the other
hand, when the patients develop complications
following the surgical procedure, they do return to
the hospital of origin.
The subtotal splenectomy was performed in
trauma only in thermodynamically unstable cases
with splenic trauma grades III and IV. Even in these
cases, during the operation we try to preserve all
organs by suturing the parenchyma or bleeding
vessels if patient is not in shock. In our experience,
many patients with splenic trauma, even with
grades III and IV, are clinically stable and do not
require operative procedure. In grade V splenic
Figure 2 Tomographic image of splenic remnant dur-
ing the late postoperative period following subtotal sple-
nectomy for splenic ischemia. Observe the splenogastric
vessels (arrow).trauma or in shock, total splenectomy and splenic
autotransplants are our surgical choice.
The outcome for patients who underwent sub-
total splenectomy in the present study was favor-
able in various aspects. Previously, we verified that
postsplenectomy infection is very rare in adults
undergoing surgery for portal hypertension due to
schistosomiasis, even without vaccination13,51 In
fact the efficacy of vaccination is complete only
in presence of spleen and when splenic tissue is
present, no specific vaccination is necessary. How-
ever some patients presented with fever episodes
without immune deficiency.13 Even though post-
splenectomy fever is frequently reported in the
literature, the exact mechanism is not completely
understood.52,53 Some of our patients presented
such episodes of fever until the late postoperative
period. Episodes of fever were not considered to
be a problem for the patients in the present study.
Pneumonia was the only severe postoperative
infection and had a benign course.
Ascites is a frequent finding in the early post-
operative period of patients with portal hyperten-
sion due to schistosomiasis. 13 Some patients may
persist with this complication for longer periods
of time. Control with diuretics is the therapeutic
regimen of choice and was employed with our pa-
tients; this complication did not represent a major
problem.
In this study we describe incisional hernias due
to failure of the supraumbilical median incision
closure. The level of care taken not to damage the
veins of the hepatic round ligament played an
important role in the development of this
Figure 3 Scintigraphic image (using 99mTc sulfur col-
loid) of a splenic remnant (arrow) after subtotal splenec-
tomy for portal hypertension.
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led us to change the operative approach to a left
medial paramedian incision. During the last
14 years, using this approach, we have not had
major incisional complications.
All patients with myeloid hepatosplenomegaly
had enlargement of the liver during the early
postoperative period. However, after 6 months
this organ reduced in size. Reportedly, the enlarge-
ment of the liver is one of the most severe compli-
cations after total splenectomy in patients with this
disorder.27e30 Lethal hemorrhages and extreme
discomfort may occur in such circumstances. We
did not find reports in the literature of a significant
hepatic reduction. In our patients, livers that in-
creased in size by 12 and 14 cm immediately after
the subtotal splenectomy are now palpable at the
level of the rib cage. We believe that partial preser-
vation of the spleen may be involved in this obser-
vation, therefore the finding should be better
evaluated.
Leukocytosis and thrombocytosis of splenectom-
ized patients have not been well explained in the
literature. The absence of clinical manifestations
indicates that this is a benign condition that should
not be called hypersplenism, which refers to a se-
vere disorder of the spleen.54 We have no data to
explain thrombocytosis in patients with subtotal
splenectomy. We believe it may be worth supposing
that after the major trauma of subtotal splenec-
tomy, the splenic tissue does not work adequately
during the early postoperative period. After its
recovery in a few weeks, the control of platelets
by the spleen is re-established and the number of
these elements decreases to normal values.
A frequent complication for patients with Gaucher’s
disease undergoing total splenectomy is severe
bone pain and frequent fractures.16,19,20 Hepatic
enlargement with functional compromise may also
occur. Our patients presented no bone complaints
and their liver enlargement was moderate.
In portal hypertension due to schistosomiasis, the
prothrombin time is almost always under 70% of the
reference time. This is not well understood, but
it does not mean coagulopathy.54 After subtotal
splenectomy, prothrombin time increased in all
patients, even in the presence of remnant splenic
tissue.
Esophageal and gastric varices of patients with
portal hypertension rarely disappear after surgical
treatment. It is of the utmost importance to relieve
internal variceal pressure. The complete absence of
late postoperative bleedings confirms the efficacy
of our procedures. Partial splenectomy with pres-
ervation of the splenic pedicle for the treatment of
portal hypertension due to schistosomiasis has beenpublished previously.55,56 However, the reported
results were not as good as those obtained in our
study, probably due to the adverse effects induced
by the maintenance of the splenic vascular pedicle.
Partial splenectomy with preservation of the
splenic pedicle usually results in splenic remnant
enlargement, provoking abdominal discomfort
especially in patients with portal hypertension,
Gaucher’s disease or myeloid hepatosplenome-
galy.20,31,32,55 This symptom by itself was an indi-
cation for surgery in the present study. The
splenogastric vessels maintain the vitality of the
upper pole. However, these vessels are incapable
of inducing enlargement of the organ or blood
supply to an enlarged spleen.49 Nevertheless, the
splenic stump maintains the functions of the organ.
Clinical, laboratory and scintigraphic studies
showed preserved function of all splenic remnants.
Further improvement of splenic function over time
was observed both experimentally and clinically in
the present investigation. The absence of splenic
images in some scintigraphies may be explained by
failures of the method, since hematological and
immunological examinations did not show signs of
asplenic process. Reportedly, inadequate tomo-
graphic and scintigraphic images may occur in 5e
30% of these tests.57e59 The factors that produce
this failure in imaging have not yet been estab-
lished. The great variation to the spleen remnant
size is due to the total amount of spleen left at the
operation depending on the extension of the splenic
trauma or number of splenogastric vessels. When
there are only one or two splenogastric vessels, it
is possible to preserve lesser amount of splenic tis-
sue than when there are more splenogastric vessels.
In conclusion, the 20 years of follow-up of pa-
tients undergoing subtotal splenectomy have shown
that this procedure should be considered for the
treatment of trauma, portal hypertension, myeloid
hepatosplenomegaly, Gaucher’s disease, spleno-
megalic retarded growth and sexual development
due to splenomegaly, severe pain due to splenic
ischemia, chronic leukemia, lymphomas and surgi-
cal disorders of the distal part of the pancreas.
This procedure may be performed by laparotomy
or laparoscopy and seems to be a safe treatment
option for conditions involving the spleen. The
functions of the splenic remnants are preserved
during long periods of time. Further studies with
larger numbers of cases should be performed to
further evaluate this therapeutic alternative.
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